Oblenio Bio
Specializes in the treatment of autoimmune diseases.
Biotechnology
📍 Cambridge, MA
Current Valuation
Private
PRIVATE
Specializes in the treatment of autoimmune diseases. Headquartered in Cambridge, MA. Raised $62M in Series B funding in June 2026 led by Pfizer Ventures.
Company Profile
Last Round
Series B — $62M (Jun 2026) · Lead: Pfizer Ventures
Fundraising Status
Series B · $62M · this month
privateTotal raised $62M1 disclosed rounds
Funding History
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series B | $62M | Jun 2026 | Pfizer Ventures | — |
Investors
Pfizer Ventures · Deep Track Capital · GV · Aditum Bio
BiotechnologyPharmaceuticalsRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.